Growth inhibition and induction of phenotypic alterations in MCF-7 breast cancer cells by an IMP dehydrogenase inhibitor.

por Sidi, Y., Panet, C., Wasserman, L., Cyjon, A., Novogrodsky, A., Nordenberg, J.
Publicado 1988

Dimethylthiourea inhibition of B16 melanoma growth and induction of phenotypic alterations; relationship to ATP levels.

por Fux, A., Sidi, Y., Kessler-Icekson, G., Wasserman, L., Novogrodsky, A., Nordenberg, J.
Publicado 1991

Novobiocin-induced anti-proliferative and differentiating effects in melanoma B16.

por Nordenberg, J., Albukrek, D., Hadar, T., Fux, A., Wasserman, L., Novogrodsky, A., Sidi, Y.
Publicado 1992

Biochemical and ultrastructural alterations accompany the anti-proliferative effect of butyrate on melanoma cells.

por Nordenberg, J., Wasserman, L., Peled, A., Malik, Z., Stenzel, K. H., Novogrodsky, A.
Publicado 1987

The anti-proliferative effect of lithium chloride on melanoma cells and its reversion by myo-inositol.

por Nordenberg, J., Panet, C., Wasserman, L., Malik, Z., Fuchs, A., Stenzel, K. H., Novogrodsky, A.
Publicado 1987

Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines

por Uziel, O, Fenig, E, Nordenberg, J, Beery, E, Reshef, H, Sandbank, J, Birenbaum, M, Bakhanashvili, M, Yerushalmi, R, Luria, D, Lahav, M
Publicado 2005

Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo

por Weiss, C, Uziel, O, Wolach, O, Nordenberg, J, Beery, E, Bulvick, S, Kanfer, G, Cohen, O, Ram, R, Bakhanashvili, M, Magen-Nativ, H, Shilo, N, Lahav, M
Publicado 2012